Novel Affibody Molecules Specifically Bind to SARS-CoV-2 Spike Protein and Efficiently Neutralize Delta and Omicron Variants
ABSTRACT The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has been an unprecedented public health disaster in human history, and its spike (S) protein is the major target for vaccines and antiviral drug development. Although widespread vaccination has been well established,...
Main Authors: | Wangqi Du, Peipei Jiang, Qingfeng Li, He Wen, Maolin Zheng, Jing Zhang, Yanru Guo, Jia Yang, Weixu Feng, Sisi Ye, Saidu Kamara, Pengfei Jiang, Jun Chen, Wenshu Li, Shanli Zhu, Lifang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2023-02-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/spectrum.03562-22 |
Similar Items
-
Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma
by: Saidu Kamara, et al.
Published: (2023-06-01) -
EBV LMP1-C terminal binding affibody molecule downregulates MEK/ERK/p90RSK pathway and inhibits the proliferation of nasopharyngeal carcinoma cells in mouse tumor xenograft models
by: Yanru Guo, et al.
Published: (2023-01-01) -
Affibody Molecules as Targeting Vectors for PET Imaging
by: Vladimir Tolmachev, et al.
Published: (2020-03-01) -
Designing, docking and heterologous expression of an anti-HER2 affibody molecule
by: N. Salmanian Tabasi, et al.
Published: (2018-02-01) -
PEG Linker Improves Antitumor Efficacy and Safety of Affibody-Based Drug Conjugates
by: Qiyu Li, et al.
Published: (2021-02-01)